NCT05856409View on ClinicalTrials.gov

Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

May 10, 2023

Primary Completion Date

April 1, 2024

Study Completion Date

December 31, 2025

Conditions
68Ga-FAPIOvarian CancerEpithelial Ovarian CancerPositron Emission Tomography
Interventions
DIAGNOSTIC_TEST

68Ga-FAPI

\[68Ga\]-FAPI is tumor imaging agent for use with Positron Emission Tomography (PET) imaging for the detection of Fibroblast Activation Protein (FAP) positive cancer cells and cancer-associated fibroblasts (CAF)

Trial Locations (1)

200127

RECRUITING

Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai

All Listed Sponsors
lead

RenJi Hospital

OTHER